Yao Wang
Wuyi University
25 Papers
61 Citations
Yao Wang is an academic researcher from Wuyi University. The author has contributed to research in topics: Chemistry & Biology. The author has an hindex of 8, co-authored 20 publications. Previous affiliations of Yao Wang include Nanchang University & Jinan University.
Chat about Author
Papers
Human Apolipoprotein A-II Protects Against Diet-Induced Atherosclerosis in Transgenic Rabbits
Yao Wang,Manabu Niimi,Kazutoshi Nishijima,Ahmed Bilal Waqar,Ying Yu,Tomonari Koike,Shuji Kitajima,Enqi Liu,Tomohiro Inoue,Masayuki Kohashi,Yuka Keyamura,Tomohiro Yoshikawa,Jifeng Zhang,Loretta Ma,Xiaohui Zha,Teruo Watanabe,Yujiro Asada,Y. Eugene Chen,Jianglin Fan,Jianglin Fan +19 more
TL;DR: Results suggest that enrichment of apo A-II in high-density lipoprotein particles has atheroprotective effects and apo B-II may become a target for the treatment of atherosclerosis.
59
Expression of Human ApoAII in Transgenic Rabbits Leads to Dyslipidemia. A New Model for Combined Hyperlipidemia
Tomonari Koike,Shuji Kitajima,Ying Yu,Ying Li,Kazutoshi Nishijima,Enqi Liu,Huijun Sun,Ahmed Bilal Waqar,Nobumitsu Shibata,Tomoriho Inoue,Yao Wang,Bo Zhang,Junji Kobayashi,Masatoshi Morimoto,Keijiro Saku,Teruo Watanabe,Jianglin Fan +16 more
TL;DR: Results indicate that apoAII plays an important role in both VLDL and HDL metabolism, possibly through the inhibition of lipoprotein lipase activity.
43
Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits
Haizhao Yan,Haizhao Yan,Manabu Niimi,Fumikazu Matsuhisa,Huanjin Zhou,Shuji Kitajima,Yajie Chen,Chuan Wang,Xiawen Yang,Jian Yao,Dongshan Yang,Jifeng Zhang,Masami Murakami,Katsuyuki Nakajima,Yao Wang,Enqi Liu,Jingyan Liang,Y. Eugene Chen,Jianglin Fan,Jianglin Fan +19 more
TL;DR: Results indicate that apoCIII deficiency facilitates TG-rich lipoprotein catabolism, and therapeutic inhibition of apo CIII expression may become a novel means not only for the treatment of hyperlipidemia but also for atherosclerosis.
31
FYN is required for ARHGEF16 to promote proliferation and migration in colon cancer cells.
Bei Yu,Linlin Xu,Limin Chen,Yao Wang,Hongying Jiang,Yiting Wang,Yehong Yan,Shiwen Luo,Zhenyu Zhai +8 more
TL;DR: It is shown that ARHGEF16 was highly expressed in clinical specimens of colon cancer and a nonreceptor tyrosine kinase, FYN, as a novel partner of ARH GEF16, which mediates colon cancer progression and is a potential therapeutic target for colon cancer treatment.
The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation
Yiting Wang,Hailong Wang,Zhengwei Yan,Guohua Li,Guohui Hu,Hong Zhang,Dengliang Huang,Yao Wang,Xiang Zhang,Yehong Yan,Quqin Lu,Minzhang Cheng,Shiwen Luo +12 more
TL;DR: TPX2 acts as a novel downstream target and effector of the Hh pathway, and Hh signaling contributes to HCC proliferation via regulating the FOXM1- TPX2 cascade, suggesting that this signaling axis may be a novel therapeutic target for HCC.